CN101991660B - Medicine composition for treating burns - Google Patents

Medicine composition for treating burns Download PDF

Info

Publication number
CN101991660B
CN101991660B CN2010105444797A CN201010544479A CN101991660B CN 101991660 B CN101991660 B CN 101991660B CN 2010105444797 A CN2010105444797 A CN 2010105444797A CN 201010544479 A CN201010544479 A CN 201010544479A CN 101991660 B CN101991660 B CN 101991660B
Authority
CN
China
Prior art keywords
grams
burn
scald
parts
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010105444797A
Other languages
Chinese (zh)
Other versions
CN101991660A (en
Inventor
刘相兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105444797A priority Critical patent/CN101991660B/en
Publication of CN101991660A publication Critical patent/CN101991660A/en
Application granted granted Critical
Publication of CN101991660B publication Critical patent/CN101991660B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine composition for treating burns, which comprises the following Chinese medical herbs in parts by weight: 80-120 parts of Chinese teasel root, 1-5 parts of borneol and 20-50 parts of pig hair. The medicine composition has the advantages of reasonable formulation and accurate treatment effect, can be used for effectively treating the burns, and has the effects of promoting blood circulation and stopping pain, diminishing the swelling and regenerating muscle skin and being free of skin grafting and leaving the scars.

Description

A kind of pharmaceutical composition of treating burn and scald
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition of treating burn and scald.
Background technology
Burn and scald is the common injury in the whole nation, and the lighter cures soon, and weight person's muscle damage is hindered to skeleton, is one of obstinate wound, also is that medical circle is paid attention to problem.This disease is that body directly contacts high temp objects or receives the strong variation that heat radiation took place.Clinical experience proves, burn and scald reaches 1/3rd of total body surface area and then can be in peril of one's life when above.
The tissue of burn and scald maybe be downright bad.When organizing burn and scald, endovascular liquid oozes out and causes tissue edema.During the large tracts of land burn and scald, vascular permeability is unusual, loses big quantity of fluid, possibly cause shock.During shock, blood pressure is very low, and the blood flow that flows to brain and other vitals reduces.
The order of severity of burn and scald depends on the scope and the degree of depth of wounded tissue, and the burn and scald degree of depth can be divided into I degree, II degree and III degree.
The damage of I degree burn and scald is the lightest.Burn and scald skin rubefaction, pain, obviously touch a tender spot, have and ooze out or edema.The part bleaches during light pressure injury, but does not have vesicle.
The damage of II degree burn and scald is darker.Skin blister.The vesicle bottom takes on a red color or white, has been full of limpid, heavy-gravity liquid.It is responsive to touch a tender spot, and bleaches during compressing.
The damage of III degree burn and scald is the darkest.Can turn white in the burn and scald surface, deliquescing or black in color, carbonization hide-like.Become pale owing to burn skin, in the pale skin people, often be mistaken as normal skin, but no longer variable color during compressing.Destructive erythrocyte can make the burn and scald local skin be cerise, and vesicle is arranged once in a while, and the hair in burn and scald district is easy to extract, and feels to go down.III degree burn and scald zone does not generally have the pain sensation.Because the teleneuron of skin is destroyed.
Do not have specially suitable medicine at present and treat burn and scald, therefore, developing a kind of medicine that effectively can treat burn and scald is very to be necessary.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition of treating burn and scald.
In order to realize the object of the invention, the present invention provides a kind of pharmaceutical composition of treating burn and scald, and it comprises following raw medicines in parts by weight: Radix Et Rhizoma Rhei 80-120 part, Borneolum Syntheticum 1-5 part, Pilus Sus domestica 20-50 part.Preferably, it comprises following raw medicines in parts by weight: 100 parts of Radix Et Rhizoma Rhei, 3 parts of Borneolum Syntheticums, 30 parts of Pilus Sus domestica.
The Radix Et Rhizoma Rhei clearing away heat-fire, induces sweat at removing pathogenic heat from blood and toxic substance from the body, the pain relieving of Borneolum Syntheticum clearing heat for detumescence, the Pilus Sus domestica granulation promoting of inducing sweat.
More preferably, pharmaceutical composition of the present invention also comprises following raw medicines in parts by weight:
Radix Angelicae Sinensis 10-20 part Rhizoma Chuanxiong 10-20 part Flos Carthami 1-5 part
The windproof 5-10 part of Herba speranskiae tuberculatae 5-10 part Radix Arnebiae (Radix Lithospermi) 1-5 part.
Pharmaceutical composition of the present invention can be processed with pharmaceutically acceptable carrier.Described pharmaceutically acceptable carrier is well known, for being used to prepare the conventional excipients or the adjuvant of above-mentioned preparation.Excipient or adjuvant commonly used comprise (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant or the like; For example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate or the like.
Usage and consumption: general traumatic condition can be smeared once on the 1st.Got final product pain relieving after the medication in ten minutes.Points for attention: avoid chicken, fish, meat, egg, Rhizoma Zingiberis Recens, pungent, Herba Coriandri, Folium Allii tuberosi, Tonnae Sinensis, bean curd, instant noodles.
Pharmaceutical composition of the present invention uses very convenient.For example can directly use with form of powder.Perhaps, can with Oleum sesami transfer be coated with or first oiling after the face reuse Oleum sesami moistening of spreading pesticides get final product, mistake was washed weary medicine off with 9% normal saline after 2-3 days, went up new drug after drying again.
The reasonable recipe of pharmaceutical composition of the present invention, curative effect is clear and definite, can be used for treating effectively burn and scald, has promoting blood circulation and stopping pain, detumescence regeneration meat skin, does not make skin graft, do not stay the effect of scar.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Radix Et Rhizoma Rhei 1000 grams, Borneolum Syntheticum 30 grams, pulverize the back and cross 80 mesh sieves.Get Pilus Sus domestica 300 grams, clean and dry, burn and process mao charcoal and cross 80 mesh sieves, then with above-mentioned powder mixes.
The preparation of embodiment 2 powder of the present invention
Get Radix Et Rhizoma Rhei 1000 grams, Borneolum Syntheticum 30 grams, pulverize the back and cross 80 mesh sieves.Get Pilus Sus domestica 300 grams, clean and dry, burn and process mao charcoal and cross 80 mesh sieves, then with above-mentioned powder mixes, as powder 1.
Get Radix Angelicae Sinensis 150 grams, Rhizoma Chuanxiong 150 grams, Flos Carthami 30 grams, Herba speranskiae tuberculatae 30 grams, windproof 50 grams, Radix Arnebiae (Radix Lithospermi) 30 grams in addition, pulverize the back and cross 80 mesh sieves.Mix with above-mentioned powder 1.
Experimental example
One, clinical data: total case load: 100 people, wherein, male 50 people account for sum 50%; Women 50 people account for sum 50%.Minimal ages 3 years old, maximum age 70 years old, the mean age is below 45 years old.I degree burn and scald 43 people wherein, II degree burn and scald 57 people.
Two, diagnostic criteria:
The damage of I degree burn and scald is the lightest.Burn and scald skin rubefaction, pain, obviously touch a tender spot, have and ooze out or edema.The part bleaches during light pressure injury, but does not have blister.
The damage of II degree burn and scald is darker.Skin blister.The blister bottom takes on a red color or white, has been full of limpid, heavy-gravity liquid.It is responsive to touch a tender spot, and bleaches during compressing.
Three, administrated method: it is preceding with burn and scald surrounding skin scrub to smear medicine, need not wrap up if smear medicine (using disinfecting cotton swab) again after having had blister to occur must it being needled, and the skin ulcer injury exposes and gets final product.100 routine patients are divided into two groups, every group 50 people.The powder of using first group of every day preparation among the embodiment 1 once; The powder of using second group of every day preparation among the embodiment 2 once.Got final product pain relieving after the medication in ten minutes.I degree burn and scald is decided to be 5 days the course of treatment, and II degree burn and scald is decided to be 10 days the course of treatment.
Four, curative effect judging standard: 1, analgesic effect: pain obviously alleviates and is that produce effects, pain relief are effectively, and pain is not seen and alleviated to invalid.2, antiinflammatory effect: inflammation not occurring is produce effects, and it is invalid inflammation occurring; 3, detumescence effect: disappearing after the medication is that produce effects, redness get better for effectively, and redness is not seen and subdued to invalid; 4, convergence, the removing the necrotic tissue granulation promoting effect of going to itch: no cicatrix is a produce effects, slight cicatrix is arranged for effectively, and cicatrix is evident as invalid.All indexs are judged to be recovery from illness for produce effects person: two or two above index produce effects, and all the other index responders are produce effects; Two or two above index nonresponders are invalid, and all the other are effective.
Five, sum up
For first group patient, wherein 48 example recoveries from illness, 2 routine produce effects.For second group patient, whole 50 examples are all fully recovered.
Six, untoward reaction
Whole 100 routine patients do not see obvious adverse reaction.

Claims (1)

1. a pharmaceutical composition of treating burn and scald is characterized in that, it prepares through following method:
Get Radix Et Rhizoma Rhei 1000 grams, Borneolum Syntheticum 30 grams, pulverize the back and cross 80 mesh sieves, get Pilus Sus domestica 300 grams, clean and dry, burn and process mao charcoal and cross 80 mesh sieves, then with above-mentioned powder mixes, as powder 1;
Get Radix Angelicae Sinensis 150 gram, Rhizoma Chuanxiong 150 grams, Flos Carthami 30 grams, Herba speranskiae tuberculatae 30 grams, windproof 50 grams, Radix Arnebiae (Radix Lithospermi) 30 grams in addition, pulverize that 80 mesh sieves are crossed in the back and above-mentioned powder 1 mixes.
CN2010105444797A 2010-11-16 2010-11-16 Medicine composition for treating burns Expired - Fee Related CN101991660B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105444797A CN101991660B (en) 2010-11-16 2010-11-16 Medicine composition for treating burns

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105444797A CN101991660B (en) 2010-11-16 2010-11-16 Medicine composition for treating burns

Publications (2)

Publication Number Publication Date
CN101991660A CN101991660A (en) 2011-03-30
CN101991660B true CN101991660B (en) 2012-04-18

Family

ID=43782737

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105444797A Expired - Fee Related CN101991660B (en) 2010-11-16 2010-11-16 Medicine composition for treating burns

Country Status (1)

Country Link
CN (1) CN101991660B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104083403A (en) * 2014-07-25 2014-10-08 秦作东 Burn and scald ointment

Also Published As

Publication number Publication date
CN101991660A (en) 2011-03-30

Similar Documents

Publication Publication Date Title
CN103705613A (en) External-use drug for treating burns and scalds
CN104001034B (en) A kind of Chinese herbal medicine unguentum treating empyrosis
CN102228485B (en) Composition for burn rehabilitation and preparation method thereof
CN103055052A (en) Cream for treating burn and scald and preparation method of cream
CN101361912A (en) Plaster for treating burn and preparation method thereof
CN101953952B (en) Powder for treating empyrosis
CN103239580B (en) Chinese medicine external application preparation for treating radioactive skin damage
CN101991660B (en) Medicine composition for treating burns
CN105412426A (en) Traditional Chinese medicine for lowering blood pressure
CN101244132A (en) Chilblain nursing liquid and preparation thereof
CN103006812B (en) Medical composition for treating burns and scalds
CN103041134A (en) Traditional Chinese medicine composition for treating vital myocarditis
CN102526494A (en) Ointment for treating burning
CN103142727B (en) Chinese herbal medicine composition for treating burning and scalding of human body
CN104800427A (en) Burn and scald recovery application and preparation method thereof
CN101401922B (en) Traditional Chinese medicine for preventing and controlling rhagadia and frostbite, and preparation method thereof
CN103157091A (en) Drug for treating empyrosis
CN104173932A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN103908526A (en) Pharmaceutical composition used for preventing or/and treating hypertension, and applications thereof
CN103893480A (en) Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility
CN102824608A (en) Externally used Chinese herba preparation for treating peripheral vascular disease
CN102940793A (en) Traditional Chinese medicine composition for treating purpura
CN106511676A (en) Traditional Chinese medicine composition for treating bedsore in clinical nursing
CN106236900A (en) A kind of for compound medicine treating burn and preparation method thereof
CN105853555A (en) Medical microfilament for treating burns and scalds and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120418

Termination date: 20161116

CF01 Termination of patent right due to non-payment of annual fee